Our comprehensive range of detection technologies, including X-ray, trace detection and infra-red spectroscopy helps customers in the global transportation, ports and borders, critical infrastructure, military and emergency responder markets.
2015 Revenue £467m
2015 Operating profit margin 11.9%
Our manufacturing centres are concentrated in Germany, France, Malaysia, USA and the UK. We sell to over 200 countries around the world either direct or through third‑party distributors.
The majority of revenues are influenced by more than 100 governments and their agencies, including homeland security authorities, customs authorities, emergency responders and the military. These include the US Department of Defense, US Transportation Security Administration (TSA), and the UK Ministry of Defence. All US sales and support activities are controlled under a Special Security Agreement with the US Department of Defense and managed by the operating subsidiary Smiths Detection Inc., to provide independent oversight of the business, its classified contracts and work.
Smiths Detection’s exposure to the homeland security and defence sectors brings it into competition with a wide range of companies in each end-use market. Principal competitors include: Morpho (transportation), Rapiscan (transportation, ports and borders, critical infrastructure), L-3 Security & Detection Systems (transportation), Nuctech (ports and borders, critical infrastructure), Astrophysics (critical infrastructure), AS&E (ports and borders), Leidos (transportation, ports and borders), Chemring (military), Bruker (military, emergency responders), and Thermo Fisher (military and emergency responders).
We are achieving increased synergies across manufacturing sites and aligning purchasing activity to ensure that we fully leverage the size of our business. These developments are ongoing and take into account the requirement for local content from some of our major customers, as well as our stringent quality and delivery standards.